What top creators are saying about Monopar Therapeutics Inc.(MNPR)

Biotech company.

1 AI-extracted insight from 1 source — podcasts, YouTube channels, and X/Twitter accounts.

Creator sentiment — last 30 days

Not enough scored insights about Monopar Therapeutics Inc. in the last 30 days yet.

Top creators covering Monopar Therapeutics Inc. (MNPR)

The 1 sources with the most insights about Monopar Therapeutics Inc. on Kazuha.

Latest insights about Monopar Therapeutics Inc. (MNPR)

AI-generated insights from podcasts, YouTube videos, and X posts — ordered by most recent.

Monday, October 6, 2025

Very Bearish

The speaker is bearish, stating the company's main drug is 'garbage' and considers the stock a 'shorter'.

Martin Shkreli
10/6/25 -20%
Martin ShkreliYouTube260 days ago

Discussed alongside Monopar Therapeutics Inc. (MNPR)

Other assets that creators frequently mention in the same content as Monopar Therapeutics Inc..

Frequently asked

Which podcasters and creators cover Monopar Therapeutics Inc. (MNPR) the most?

The most active sources covering Monopar Therapeutics Inc. (MNPR) on Kazuha are @realmartinshkreli. Kazuha aggregates AI-extracted insights from podcasts, YouTube channels, and X/Twitter accounts.

How many insights about Monopar Therapeutics Inc. (MNPR) are on Kazuha?

Kazuha has indexed 1 AI-extracted insight about Monopar Therapeutics Inc. (MNPR) from 1 different source. New insights are added whenever a covered creator publishes a new podcast episode, video, or post.

What other assets do creators discuss alongside Monopar Therapeutics Inc. (MNPR)?

Creators covering Monopar Therapeutics Inc. (MNPR) most frequently also discuss RGTI, QUBT, IONQ, ANAB, JNJ. See the "Discussed alongside" section above for full asset pages.